Evidence map›Paper›PMID 41677945›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2026

Predicting health-related quality of life two years post-diagnosis across seven cancer types: using machine learning to identify vulnerable patients.

Willemijn F Oudijk, Belle H de Rooij, Koen J van Benthem, Rampal S Etienne, Simone Oerlemans, Helena M Verkooijen, Katja K H Aben, Geraldine R Vink, Anne M May, Floortje Mols and 2 more

Abstract read
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Willemijn F OudijkDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.ORCID http://orcid.org/0009-0000-0801-8262
Belle H de RooijDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-0172-0857
Koen J van BenthemGroningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-3841-2110
Rampal S EtienneGroningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0003-2142-7612
Simone OerlemansDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-1595-7262
Helena M VerkooijenUniversitair Medisch Centrum Utrecht, Divisie Beeld, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0001-9480-1623
Katja K H AbenDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-0214-2147
Geraldine R VinkDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-6731-9660
Anne M MayJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-0643-3790
Floortje MolsDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-0818-2913
Dimitris KatsimpokisDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-4073-0206
Nicole P M EzendamDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands. n.p.m.ezendam@tilburguniversity.edu.ORCID http://orcid.org/0000-0002-5878-4210

Funding

KWF Kankerbestrijding 2013-5942KWF Kankerbestrijding 2015-7914KWF Kankerbestrijding UVA 2013-6331KWF Kankerbestrijding UVT 2010-4743Netherlands Organization for Scientific Research 2016/04981/ZONMW-91101002
6 · The paper itself

Abstract

purposeCancer survivors often experience long-term consequences affecting their Health-Related Quality of Life (HRQoL). Sociodemographic factors, clinical characteristics, and health-related behaviours influence HRQoL, making some individuals vulnerable to adverse HRQoL. This study develops linear regression and machine learning models to predict HRQoL two-year post-diagnosis and to identify key vulnerability factors.

methodsThis longitudinal study included data of survivors of seven cancer types. Nineteen predictor variables were derived from questionnaires completed within three months post-diagnosis (baseline) from the Netherlands Cancer Registry. Linear regression, random forest, XGBoost, neural network, and Support Vector Machine (SVM) regressors were employed to predict the EORTC QLQ-C30 summary score 1.5-2.5 years post-diagnosis. Permutation testing assessed vulnerability factors.

resultsThe analyses included 4,538 individuals. All models achieved similar R

conclusionsThe predictors used in this analysis explained only 30% of the variation in long-term HRQoL. Similar to previous studies predicting HRQoL in cancer, these predictors miss crucial information. Baseline functioning, comorbidities, cancer type and BMI appeared to be the key vulnerability factors. Future studies should prioritize accurate prediction of low HRQoL scores.

Indexed as

Cancer SurvivorsMachine LearningNeoplasmsQuality of LifeVulnerable PopulationsAdultAgedBoosting Machine Learning AlgorithmsClassification AlgorithmsFemaleHumansLinear ModelsLongitudinal StudiesMaleMiddle AgedNetherlandsCancer survivorshipHealth-related quality of life (HRQoL)Long-term consequencesMachine learningPredictive modellingVulnerability factors

Identifiers

PMID41677945
PMCPMC12901195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.